SUPN  valuation analysis

Basics
Name: Supernus Pharmaceuticals Inc
Description: Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 13, 2022
Market cap: $1.48B (1122nd)
Sales(TTM): $607.89M (1186th)
Earnings(TTM): $50.17M (1123rd)

Value
FFER: 1.24 (why)
Actual price: $27.27
FFEThis is Supernus Pharmaceuticals Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $22.04
Quantile: SUPN is expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Supernus Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Supernus Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Supernus Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Supernus Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry